American Portfolios Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

American Portfolios Advisors’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$6.8K	–	2625
2018 Q3	$6.8K	Sell	2,000 -2,000	-50%	-$7.21K	﹤0.01%	1897
2018 Q2	$15K	Hold	4,000	–	–	﹤0.01%	1563
2018 Q1	$16.4K	Hold	4,000	–	–	﹤0.01%	1453
2017 Q4	$18.6K	Buy	+4,000	New	+$22K	﹤0.01%	1353

American Portfolios Advisors's KERX Position: Q4 2018 in Review

American Portfolios Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 2,000 shares — an estimated $6.8K sold.

American Portfolios Advisors first reported a position in KERX in Q4 2017 and held it in 4 quarters. The position peaked at $18.6K in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

American Portfolios Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
American Portfolios Advisors sold 2,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $6.8K.
American Portfolios Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
American Portfolios Advisors's Keryx Biopharmaceuticals Inc position peaked at $18.6K in Q4 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on American Portfolios Advisors's 13F filing for Q4 2018, filed 24 Mar 2023.